Clinical Trial Update: Safety Study of Regimens of Sofosbuvir, GS-0938, and Ribavirin in Patients With Chronic Hepatitis C Infection [Phase 2]

View source ↗

Summary

A Phase 2 safety study evaluating regimens of Sofosbuvir, GS-0938, and Ribavirin in patients with chronic hepatitis C infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• GS-0938
• Ribavirin (ribavirin)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C, Chronic | Phase 2 | Status: COMPLETED